Catherine T. Doherty Quest Diagnostics Inc (DGX) insider trading activity

Catherine T. Doherty is EVP, Regional Businesses of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 68,068 shares of DGX, which is worth approximately $9.33 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 5,370 shares (Common Stock) at a price of $174.13 per share, resulting in proceeds of $935,078. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.1K

0.5% 3M change

0.5% 12M change

Total Value Held $9.33 Million

Catherine T. Doherty Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Open market or private sale	$935,078 $174.13 p/Share	5,370 Reduced 7.31%	68,068 Common Stock
Mar 04 2025	SELL Open market or private sale	$125,865 $175.79 p/Share	716 Reduced 1.04%	68,068 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$870,437 $173.74 p/Share	5,010 Reduced 6.39%	73,438 Common Stock
Mar 04 2025	BUY Grant, award, or other acquisition	$1,803,421 $173.74 p/Share	10,380 Added 11.69%	78,448 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$68,453 $173.74 p/Share	394 Reduced 0.57%	68,784 Common Stock
Feb 27 2025	SELL Open market or private sale	$142,230 $172.61 p/Share	824 Reduced 1.18%	69,178 Common Stock
Feb 26 2025	SELL Payment of exercise price or tax liability	$78,146 $171.75 p/Share	455 Reduced 0.65%	70,002 Common Stock
Feb 20 2025	SELL Open market or private sale	$153,720 $170.99 p/Share	899 Reduced 1.26%	70,457 Common Stock
Feb 19 2025	SELL Open market or private sale	$90,794 $169.71 p/Share	535 Reduced 0.74%	71,356 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	3,479 Added 4.62%	71,891 Common Stock
Nov 27 2024	SELL Open market or private sale	$5,383,871 $162.64 p/Share	33,103 Reduced 32.61%	68,412 Common Stock
Nov 27 2024	BUY Exercise of conversion of derivative security	$3,428,477 $103.57 p/Share	33,103 Added 24.59%	101,515 Common Stock
Feb 29 2024	SELL Open market or private sale	$149,419 $125.88 p/Share	1,187 Reduced 1.71%	68,412 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$151,758 $126.36 p/Share	1,201 Reduced 1.57%	75,156 Common Stock
Feb 28 2024	SELL Open market or private sale	$703,349 $126.57 p/Share	5,557 Reduced 7.39%	69,599 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$469,700 $125.02 p/Share	3,757 Reduced 4.69%	76,357 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	$1,164,436 $125.02 p/Share	9,314 Added 10.42%	80,114 Common Stock
Feb 22 2024	SELL Open market or private sale	$103,560 $126.14 p/Share	821 Reduced 1.15%	70,800 Common Stock
Feb 21 2024	SELL Payment of exercise price or tax liability	$61,634 $125.02 p/Share	493 Reduced 0.68%	71,621 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	4,304 Added 5.63%	72,114 Common Stock
Mar 07 2023	SELL Open market or private sale	$745,898 $140.55 p/Share	5,307 Reduced 7.26%	67,810 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$681,634 $147.86 p/Share	4,610 Reduced 5.93%	73,117 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	$1,466,327 $147.86 p/Share	9,917 Added 11.32%	77,727 Common Stock
Mar 03 2023	SELL Open market or private sale	$100,831 $140.63 p/Share	717 Reduced 1.05%	67,810 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$55,150 $140.69 p/Share	392 Reduced 0.57%	68,527 Common Stock

CTD

Catherine T. Doherty

EVP, Regional Businesses

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account